Ovarian ablation in early breast cancer: overview of the randomised trials

Ovarian ablation in early breast cancer: overview of the randomised trials

<p><strong>Background</strong> Among women with early breast cancer, the effects of ovarian ablation on recurrence and death have been assessed by several randomised trials that now have long follow-up. In this report, the Early Breast Cancer Trialists' Collaborative Group pre...

Bibliografski detalji
Glavni autor:	Early Breast Cancer Trialists' Collaborative Group
Daljnji autori:	Clarke, M
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 1996

Slični predmeti

Polychemotherapy for early breast cancer: an overview of the randomised trials
od: Early Breast Cancer Trialists' Collaborative Group
Izdano: (1998)

Tamoxifen for early breast cancer: an overview of the randomised trials
od: Early Breast Cancer Trialists' Collaborative Group
Izdano: (1998)

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
od: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Izdano: (2005)

Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials
od: Early Breast Cancer Trialists' Collaborative Group
Izdano: (1995)

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
od: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Izdano: (2005)

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
od: Early Breast Cancer Trialists’ Collaborative Group
Izdano: (2017)

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials
od: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Izdano: (2022)

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
od: Early Breast Cancer Trialists’ Collaborative group (EBCTCG)
Izdano: (2021)

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
od: Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Izdano: (2010)

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
od: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Izdano: (2008)

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
od: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Izdano: (2011)

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
od: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Izdano: (2011)

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer
od: Early Breast Cancer Trialists' Collaborative Group
Izdano: (1988)

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
od: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Izdano: (2011)

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
od: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Izdano: (2014)

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
od: Early Breast Cancer Trialist's Collaborative Group
Izdano: (1992)

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition)
od: Committee of Breast Cancer Society, China Anti-Cancer Association
Izdano: (2024-03-01)

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2021 CACA-CBCS
od: Chinese Anti-Cancer Association, Committee of Breast Cancer Society
Izdano: (2022-02-01)

Overview of the Randomised Trials of Radiotherapy in Early Breast Cancer.
od: Darby, S, i dr.
Izdano: (2009)

Chinese expert consensus recommendations for management of bone health in female patients with early breast cancer (2022 edition)
od: The Society of Breast Cancer of China Anti-Cancer Association, Breast Cancer Study Group Along Yangtze River
Izdano: (2022-03-01)

WITHDRAWN: Ovarian ablation for early breast cancer.
od: Clarke, M
Izdano: (2008)

20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years
od: Pan, H, i dr.
Izdano: (2017)

Screening and early diagnosis of breast cancer in China: a practice guideline
od: The Society of Breast Cancer, China Anti-Cancer Association
Izdano: (2022-04-01)

Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.
od: Collaborative Group on Epidemiological Studies of Ovarian Cancer
Izdano: (2012-01-01)

Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials.
od: CLL Trialists’ Collaborative Group
Izdano: (2012)

Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition)
od: The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
Izdano: (2023-12-01)

Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials
od: CLL Trialists’ Collaborative Group (CLLTCG)
Izdano: (2012-03-01)

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.
od: Stem Cell Trialists' Collaborative Group
Izdano: (2005)

Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis.
od: Stroke Thrombolysis Trialists' Collaborative Group
Izdano: (2013)

Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
od: Expert group of expert consensus on neoadjuvant treatment of breast cancer in China ( edition)
Izdano: (2022-01-01)

The benefits and harms of breast cancer screening: an independent review.
od: Independent UK Panel on Breast Cancer Screening
Izdano: (2012)

Expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition)
od: Committee of Breast Cancer Society, Chinese Anti-Cancer Association, Breast Surgeons Committee of Surgeons Branch, Chinese Medical Doctor Association, Committee of Breast Cancer Society, Shanghai Anti-Cancer Association
Izdano: (2022-09-01)

Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial
od: Erwin Birnie, i dr.
Izdano: (2021-09-01)

Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies.
od: Isabel dos Santos Silva, i dr.
Izdano: (2008-09-01)

The role of hormonal ovarian ablation in adjuvant treatment of premenopausal breast cancer
od: Murtezani Zafir, i dr.
Izdano: (2011-01-01)

Caesarean section surgical techniques: a randomised factorial trial (CAESAR).
od: CAESAR study collaborative group
Izdano: (2010)

Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer.
od: Cong Xue, i dr.
Izdano: (2016-01-01)

Early breast cancer - the randomised evidence
od: Peto, R, i dr.
Izdano: (1999)

NOTIFICATION: Development of a Novel Approach for Breast Cancer Prediction and Early Detection Using Minimally Invasive Procedures and Molecular Analysis: How Cytomorphology Became a Breast Cancer Risk Predictor
od: The Breast Journal
Izdano: (2025-01-01)

Chinese consensus of cardio-oncology in breast cancer
od: SHEN Zan, SHAO Zhimin, Cancer Support Rehabilitation Therapy Group of Chinese Medical Association Oncology Branch, the Drafting Committee of China Breast Cancer Related Heart Disease Diagnosis and Treatment Consensus
Izdano: (2022-10-01)